For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

In the PURPOSE 2 trial, lenacapavir offered almost complete protection to cisgender men, transgender women, transgender men, ...

The shot was 100% effective in preventing HIV infections in a study of women, and results published Wednesday show it worked ...

Colombia hosts the largest population of migrants and refugees from Venezuela, where more than 7.7 million have left since ...

Matías Tarnopolsky will become president and CEO of the New York Philharmonic on Jan. 1, after four years heading the ...

Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

In Argentina, patients and medical professionals are alarmed by President Javier Milei's proposed spending cuts that are affecting HIV/AIDS treatment and prevention. The austerity measures, aimed at ...

It’s been called the closest the world has ever come to a vaccine against AIDS. The twice-yearly shot was 100% effective in ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...